Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Marc Cohn is walking in his truth. The 65-year-old singer, whose “Walking in Memphis” single took the world by storm in the ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

The co-presenter of the Movers And Shakers podcast, about life with Parkinson’s and which has previously featured ... their ...

Kevin Hill, 65, used to suffer sleepless nights due to his harrowing Parkinson's disease symptoms. Now, he forgets about his ...

On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Music has the best chance of providing pain relief when it is played at our natural rhythm, a McGill University research team ...

“I am talking about chronic pain, addiction, neurooncology ... treatment for movement disorders such as essential tremor and Parkinson’s disease. (Mike Stocker/South Florida Sun Sentinel ...